IPHYF
Innate Pharma S.A.
Set alert
1.51 USD 0.00 0.00%
2.18 Day range 2.25
1.37 52-week range 2.25
- YTD
- -29.81%
- 1 year
- -24.55%
- Open
- 2.18
- Prev close
- 1.51
- Mkt cap
- 168.56M
- Vol
- 200
- Avg vol
- 15
- EPS
- -0.59
- P/E
- 0.00
More statistics
- Low
- 2.18
- High
- 2.25
- Earnings
- Mar 21, 2024
News
4 days ago businesswire.com
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
MARSEILLE, France--(BUSINESS WIRE)---- $IPH #ADC--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that AstraZeneca has updated the…